[3H]DuP 753, a highly potent and specific radioligand for the angiotensin II-1 receptor subtype

https://doi.org/10.1016/0006-291X(90)91575-DGet rights and content

Abstract

[3H]DuP 753, a nonpeptide angiotensin II (AII) receptor antagonist radioligand, was used to characterize a subtype of AII receptors in rat adrenal cortical microsomes. By Scatchard analysis, a single class of DuP 753 binding sites was found with an affinity of 6.4 nM and a Bmax of 1.3 pmol/mg protein. These sites were saturable and readily reversible. Angiotensin (I, II, III) expressed the same affinities and order of potency for these binding sites as those labeled by [3H]AII for the AII-1 sites. The affinities expressed by nonpeptide AII antagonists were commensurate with their inhibitory potencies on AII-1 receptors. PD123177, an AII-2 specific ligand, and other non-AII peptides showed no inhibitory action. These data together with the differential tissue distribution strongly support our conclusion that [3H]DuP 753 is a potent and highly specific radioligand for the AII-1 receptors.

References (22)

  • S. Gunther

    J. Biol. Chem

    (1984)
  • S. Whitebread et al.

    Biochem. Biophys. Res. Comm

    (1989)
  • A.T. Chiu et al.

    Biochem. Biophys. Res. Commun

    (1989)
  • A.T. Chiu et al.

    Eur. J. Pharmacol

    (1988)
  • A.T. Chiu et al.

    Eur. J. Pharmacol

    (1989)
  • M.J. Peach et al.

    J. Pharmacol. Exp. Ther

    (1969)
  • M.J. Peach et al.

    Adv. Exp. Med

    (1980)
  • A.T. Chiu et al.
  • C.A. Sarstedt et al.

    Circ. Res

    (1975)
  • M.T. Schiavone et al.
  • J.G. Douglas

    Am. J. Physiol

    (1987)
  • Cited by (88)

    • Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease

      2016, Pharmacology and Therapeutics
      Citation Excerpt :

      Such additional effects may occur as a result of vasodilation, often assessed as blood pressure (BP) lowering or, at least in part, independently of it. All clinically used ARBs have high selectivity for AT1R over angiotensin II type 2 receptors (AT2R) as shown for azilsartan (Ojima et al., 2011), candesartan (Shibouta et al., 1993), eprosartan (Keiser et al., 1995), irbesartan (Cazaubon et al., 1993), losartan (Chiu et al., 1990a), olmesartan (Mizuno et al., 1995), telmisartan (Wienen et al., 1993) or valsartan (Criscione et al., 1993). Most ARBs have also high selectivity for AT1R as compared to molecular targets outside the RAS.

    • Pharmacological properties of angiotensin II receptors in cultured rabbit gingival fibroblasts

      2004, Comparative Biochemistry and Physiology - C Toxicology and Pharmacology
    • Central AII evokes a normal sodium appetite in the Fischer rat, but its low spontaneous sodium intake may be related to reduced excitation and increased inhibition in septo-preoptic AII neurons

      2004, Brain Research Bulletin
      Citation Excerpt :

      Central administration (i.c.v.) of the peptide hormone angiotensin II (AII) stimulates thirst, blood pressure responses and a significant appetite for hypertonic sodium chloride solutions. This natriophilic action of AII has been proposed to be mediated by the AII type 1 (AT1) receptor [6,10,13,31,36,41] since it is blocked, like AII-induced increases in water intake and blood pressure, by central injection of high (mmol) doses of the non-peptide AT1 receptor-specific antagonists losartan (Los) [1,2,7,12,21,22,41] or irbesartan (Irb) [8,14,15]. In the anterior, medial, forebrain, which is involved in hydromineral regulation [17,37,39,40] and also contains receptors for AII [25], iontophoretic application of AII in Wistar rats produces either an increase in spontaneous activity (excitation) or a decrease in activity (inhibition), depending on the neuron [16,35,40].

    View all citing articles on Scopus
    View full text